| Dr Daniel Barker, MD | |
|
2700 Westside Dr Nw Ste 201, Cleveland, TN 37312-3699 | |
| (423) 244-9225 | |
| (423) 244-9227 |
| Full Name | Dr Daniel Barker |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 2700 Westside Dr Nw Ste 201, Cleveland, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023277860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD52501 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tennova Health Care-cleveland | Cleveland, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Medical Clinic Inc | 0446164404 | 21 |
News Archive
A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.
› Verified 9 days ago
| Entity Name | Cleveland Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457350951 PECOS PAC ID: 0446164404 Enrollment ID: O20040827000734 |
News Archive
A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.
› Verified 9 days ago
| Entity Name | Head & Neck Specialties, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750570974 PECOS PAC ID: 2668661877 Enrollment ID: O20110104000581 |
News Archive
A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Barker, MD 2700 Westside Dr Nw Ste 201, Cleveland, TN 37312-3699 Ph: (423) 244-9225 | Dr Daniel Barker, MD 2700 Westside Dr Nw Ste 201, Cleveland, TN 37312-3699 Ph: (423) 244-9225 |
News Archive
A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.
NovaBay Pharmaceuticals, Inc. announced today that the latest public data on its Aganocide® compounds, a new class of broad-spectrum antimicrobials, will be presented during three poster sessions at the Association for Research in Vision and Ophthalmology annual meeting in Fort Lauderdale, Florida.
Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.
UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.
› Verified 9 days ago
Mr. Jack P. Byrd, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2414 Chambliss Ave N.w., Cleveland, TN 37311 Phone: 423-472-6581 Fax: 423-472-2425 | |
Kenneth Hugh Mccarley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2414 Chambliss Ave Nw, Cleveland, TN 37311 Phone: 423-472-6581 Fax: 423-472-2425 | |
Dr. Albert Anthony Clairmont Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2700 Westside Dr Nw, Suite 308, Cleveland, TN 37312 Phone: 423-479-4132 Fax: 423-478-5347 | |
Timothy Allen Viser, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2414 Chambliss Avenue, Cleveland, TN 37320 Phone: 423-472-6581 Fax: 423-472-2425 |